'Hr 95 ci' presentation slideshows

Al B. Benson III, MD, FACP Professor of Medicine Associate Director for Clinical Investigations

Biomarker-Driven Design: Complexities Using A Colon Cancer Model. Al B. Benson III, MD, FACP Professor of Medicine Associate Director for Clinical Investigations Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Prognostic Markers versus Predictive Markers.

619 views • 50 slides

Adjuvant Chemotherapy in Early Colorectal cancer Siew Wei Wong

Adjuvant Chemotherapy in Early Colorectal cancer Siew Wei Wong. Colon Cancer | Epidemiology- Australia. Most common cancers 2012. Cancer related deaths 2010. 14,410 new cases diagnosed in 2010 More common in Men 1:17 M, 1:26 F. Australian Institute of Health and Welfare.

590 views • 48 slides

Axel Grothey, MD Professor of Oncology Mayo Clinic College of Medicine Rochester, MN

A Report from ASCO-GI 2008 and ASCO 2007 Up-to-Date Review of the Treatment of Adjuvant Colorectal Cancer. Axel Grothey, MD Professor of Oncology Mayo Clinic College of Medicine Rochester, MN. History of Adjuvant Therapy of Colon Cancer. 5-FU/LV superior to 5-FU/lev

620 views • 45 slides

TRAITEMENT ADJUVANT et NEO-ADJUVANT DU CANCER COLO-RECTAL

729 views • 43 slides

HORIZONS AMI Trial

539 views • 36 slides

Aimery de Gramont

Aimery de Gramont.

409 views • 26 slides

Dr. Harvey White on behalf of the ACUITY investigators

ACUITY PCI A Prospective Trial of Patients with ACS Undergoing PCI after Randomization to Heparin plus GP IIb/IIIa Inhibitors vs. Bivalirudin With or Without GP IIb/IIIa Inhibitors.

344 views • 25 slides

Presenter Disclosure Information

Safety and Efficacy of Bivalirudin in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Medical Management: One Year Results from the Randomized ACUITY Trial.

317 views • 23 slides

Presenter Disclosure Information

Safety and Efficacy of Bivalirudin in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing Medical Management: One Year Results from the Randomized ACUITY Trial.

372 views • 23 slides

I-PRESERVE Trial Irbesartan in heart failure with preserved EF

I-PRESERVE Trial Irbesartan in heart failure with preserved EF. Executive Committee M. Komajda, R. McKelvie, J. McMurray, M. Zile, C. Staiger, A. Ptaszynska. Co-PIs: Peter Carson and Barry Massie. On behalf of the I-PRESERVE Committees and Investigators. Presenter Disclosure Information.

292 views • 20 slides

F.H. Verbrugge , J. Duchenne , M. Dupont, W. Mullens

290 views • 11 slides